# Current Context

Latest checkpoint: `150_catalog-integrity-and-71-biomarker-hardening.md`
Progress: `150%`

## Compressed State

Expanded catalog to 71 biomarkers across metabolic, lipid, renal, liver, thyroid, inflammation, CBC, differential, coagulation, blood gas, cardiac, and urinalysis panels. Corrected catalog LOINC metadata, preserved blank-unit urinalysis reference ranges, and aligned customer-facing docs with the validated 84.7% combined mapping rate on 128K rows.

## Locked Decisions

- Serum/plasma biomarkers also accept whole_blood specimen (generic Blood reporting)
- LOINC long-form aliases added for Synthea/EHR compatibility
- FHIR ingest auto-detected by .json extension
- Sample data excluded from git via .gitignore
- Blank-unit reference ranges are valid for unitless biomarkers and should be preserved
- Catalog LOINC edits require regression checks, not just spot inspection

## Immediate Next Steps

- Re-run large-sample validation after the 71-biomarker hardening pass
- Consider HL7v2 ingest for enterprise customers
- Expand vendor alias coverage with real customer data
- Add broader metadata sanity checks for future catalog expansion waves

## Resume From

Start from project_memory/current_context.md. The toolkit now has 71 biomarkers, corrected LOINC metadata, preserved urinalysis range handling, and synced docs/project memory. Next focus should be broader validation and the next customer-driven coverage wave.
